老年骨髓瘤患者早期骨髓瘤相关死亡:临床预后评分开发及缓解可持续性作用的评估
研究纳入两项西班牙试验中490例新诊断老年骨髓瘤患者,68例(13.8%)在诊断后2年内死于骨髓瘤进展。基于乳酸脱氢酶升高、ISS 3期、高危细胞遗传学或年龄>75岁4项简易指标构建的评分模型可 upfront 识别这些患者;缓解不持续(持续时间<6个月)是与骨髓瘤进展相关死亡风险显著增加相关的重要预测因素。
要点
- 490例新诊断老年骨髓瘤患者中68例(13.8%)在诊断后2年内死于骨髓瘤进展。
- 基于乳酸脱氢酶升高、ISS 3期、高危细胞遗传学或年龄>75岁的简易评分模型可 upfront 识别早期死亡高危患者。
- 缓解不持续(持续时间<6个月)与骨髓瘤进展相关死亡风险显著增加相关。
核心结论
- 基于乳酸脱氢酶升高、ISS 3期、高危细胞遗传学或年龄>75岁4项广泛可用指标的简易评分模型有助于 upfront 识别2年内死于骨髓瘤进展的老年骨髓瘤患者。
- 缓解不持续(持续时间<6个月)是与骨髓瘤进展相关死亡风险显著增加相关的重要预测因素。
- 识别早期死亡高危患者对旨在维持首次缓解深度的创新试验具有相关性,因为其中许多患者将无法接受后续治疗线。
研究设计与样本
- 评估两项西班牙试验(GEM2005-GEM2010)纳入的490例新诊断老年骨髓瘤患者的结局。
主要发现
- 68例患者(13.8%)在诊断后2年内死于骨髓瘤进展(早期死亡)。
- 缓解不持续(持续时间<6个月)与骨髓瘤进展相关死亡风险显著增加相关。
关键数值与推荐
- 简易评分模型基于4项广泛可用指标:乳酸脱氢酶升高、ISS 3期、高危细胞遗传学或年龄>75岁。
- 早期死亡定义为诊断后2年内死于骨髓瘤进展,发生率为13.8%(68/490)。
- 缓解不持续定义为缓解持续时间<6个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although survival of elderly myeloma patients has significantly improved there is still a subset of patients who, despite being fit and achieving optimal responses, will die within 2 years of diagnosis due to myeloma progression. The objective of this study was to define a scoring prognostic index to identify this group of patients. We have evaluated the outcome of 490 newly diagnosed elderly myeloma patients included in two Spanish trials (GEM2005-GEM2010). Sixty-eight patients (13.8%) died within 2 years of diagnosis (early deaths) due to myeloma progression. Our study shows that the use of simple scoring model based on 4 widely available markers (elevated LDH, ISS 3, high risk CA or >75 years) can contribute to identify up-front these patients. Moreover, unsustained response (<6 months duration) emerged as one important predictor of early myeloma-related mortality associated with a significant increase in the risk of death related to myeloma progression. The identification of these patients at high risk of early death is relevant for innovative trials aiming to maintain the depth of first response, since many of them will not receive subsequent lines of therapy.
引用
- Rodríguez-Otero P, Mateos MV, Martínez-López J, et al. Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role. Leukemia. 2018. PMID: 29515235. doi:10.1038/s41375-018-0072-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。